Medtronic Management
Management criteria checks 3/4
Medtronic's CEO is Geoff Martha, appointed in Apr 2020, has a tenure of 3.25 years. total yearly compensation is $16.85M, comprised of 8% salary and 92% bonuses, including company stock and options. directly owns 0.002% of the company’s shares, worth $2.64M. The average tenure of the management team and the board of directors is 3.3 years and 8.5 years respectively.
Key information
Geoff Martha
Chief executive officer
US$16.8m
Total compensation
CEO salary percentage | 8.0% |
CEO tenure | 3.3yrs |
CEO ownership | 0.002% |
Management average tenure | 3.3yrs |
Board average tenure | 8.5yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Apr 28 2023 | n/a | n/a | US$4b |
Jan 27 2023 | n/a | n/a | US$4b |
Oct 28 2022 | n/a | n/a | US$4b |
Jul 29 2022 | n/a | n/a | US$5b |
Apr 29 2022 | n/a | n/a | US$5b |
Jan 28 2022 | n/a | n/a | US$5b |
Oct 29 2021 | n/a | n/a | US$5b |
Jul 30 2021 | n/a | n/a | US$4b |
Apr 30 2021 | US$16m | US$1m | US$4b |
Jan 29 2021 | n/a | n/a | US$3b |
Oct 30 2020 | n/a | n/a | US$4b |
Jul 31 2020 | n/a | n/a | US$4b |
Apr 24 2020 | US$6m | US$905k | US$5b |
Jan 24 2020 | n/a | n/a | US$5b |
Oct 25 2019 | n/a | n/a | US$5b |
Jul 26 2019 | n/a | n/a | US$4b |
Apr 26 2019 | US$4m | US$693k | US$5b |
Compensation vs Market: Geoff's total compensation ($USD16.85M) is above average for companies of similar size in the AR market ($USD5.70M).
Compensation vs Earnings: Geoff's compensation has been consistent with company performance over the past year.
CEO
Geoff Martha (53 yo)
3.3yrs
Tenure
US$16,849,633
Compensation
Mr. Geoffrey Straub Martha, also known as Geoff, serves as Director at Medtronic plc since November 01, 2019 and serves as its Chief Executive Officer since April 27, 2020. He serves as Chairman at Medtron...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman of the Board & CEO | 3.3yrs | US$16.85m | 0.0023% $ 2.6m | |
Executive VP & CFO | 7.1yrs | US$7.14m | 0.00025% $ 289.8k | |
Executive VP | 1.4yrs | US$11.72m | 0.00057% $ 660.8k | |
Executive VP & President of Global Regions | 8.5yrs | US$5.66m | 0.0033% $ 3.8m | |
Executive VP & President of Medical Surgical Portfolio | 8.5yrs | US$6.03m | 0.0012% $ 1.4m | |
Senior Vice President of Global Operations and Business Services | 6.8yrs | no data | no data | |
Senior VP | 2.1yrs | no data | 0.00076% $ 881.1k | |
Senior VP and Chief Technology & Innovation Officer | less than a year | no data | no data | |
Senior VP and Chief Scientific | 1.3yrs | no data | no data | |
VP & Head of Investor Relations | 8.1yrs | no data | no data | |
Senior VP & Chief Communications Officer | 2.5yrs | no data | no data | |
Executive VP & President of Cardiovascular Portfolio | no data | no data | 0.0013% $ 1.5m |
3.3yrs
Average Tenure
59yo
Average Age
Experienced Management: MDTD's management team is considered experienced (3.3 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman of the Board & CEO | 3.7yrs | US$16.85m | 0.0023% $ 2.6m | |
Independent Director | 10.5yrs | US$402.83k | 0.00096% $ 1.1m | |
Independent Director | 16.5yrs | US$350.03k | 0.0014% $ 1.6m | |
Independent Director | 8.5yrs | US$376.63k | 0.0031% $ 3.6m | |
Independent Director | 21.5yrs | US$365.03k | 0.0065% $ 7.6m | |
Lead Independent Director | 8.5yrs | US$376.43k | 0.0026% $ 3.0m | |
Independent Director | 23.5yrs | US$370.83k | 0.0053% $ 6.2m | |
Independent Director | 4.3yrs | US$353.23k | 0.00032% $ 371.0k | |
Independent Director | 9.5yrs | US$382.63k | 0.00088% $ 1.0m | |
Independent Director | 1.1yrs | no data | no data | |
Independent Director | 2.8yrs | US$365.83k | 0.00017% $ 197.1k |
8.5yrs
Average Tenure
65yo
Average Age
Experienced Board: MDTD's board of directors are considered experienced (8.5 years average tenure).